These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 22217532

  • 1. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
    Kubal C, Cockwell P, Gunson B, Jesky M, Hanvesakul R, Dronavalli V, Bonser RS, Neil D.
    Transplantation; 2012 Feb 27; 93(4):406-11. PubMed ID: 22217532
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function.
    Lee JP, Heo NJ, Joo KW, Yi NJ, Suh KS, Moon KC, Kim SG, Kim YS.
    Nephrol Dial Transplant; 2010 Aug 27; 25(8):2772-85. PubMed ID: 20207711
    [Abstract] [Full Text] [Related]

  • 3. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
    Horike K, Takeda A, Yamaguchi Y, Ogiyama Y, Yamauchi Y, Murata M, Kawaguchi T, Suzuki T, Otsuka Y, Inaguma D, Goto N, Watarai Y, Uchida K, Morozumi K.
    Clin Transplant; 2011 Jul 27; 25 Suppl 23():23-7. PubMed ID: 21623910
    [Abstract] [Full Text] [Related]

  • 4. Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.
    Bröcker V, Schubert V, Scheffner I, Schwarz A, Hiss M, Becker JU, Scherer R, Haller H, Kreipe HH, Mengel M, Gwinner W.
    Am J Pathol; 2012 May 27; 180(5):1852-62. PubMed ID: 22464889
    [Abstract] [Full Text] [Related]

  • 5. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 27; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 6. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, Haberal M.
    Transplant Proc; 2009 Sep 27; 41(7):2789-93. PubMed ID: 19765436
    [Abstract] [Full Text] [Related]

  • 7. The natural history of chronic allograft nephropathy.
    Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR.
    N Engl J Med; 2003 Dec 11; 349(24):2326-33. PubMed ID: 14668458
    [Abstract] [Full Text] [Related]

  • 8. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED.
    J Heart Lung Transplant; 2009 Jun 11; 28(6):564-71. PubMed ID: 19481016
    [Abstract] [Full Text] [Related]

  • 9. Histopathology of renal failure after heart transplantation: a diverse spectrum.
    Pinney SP, Balakrishnan R, Dikman S, Nair A, Hammond K, Domanski M, Anyanwu AC, Deboccardo G.
    J Heart Lung Transplant; 2012 Mar 11; 31(3):233-7. PubMed ID: 21945725
    [Abstract] [Full Text] [Related]

  • 10. The variable pathology of kidney disease after liver transplantation.
    Kim JY, Akalin E, Dikman S, Gagliardi R, Schiano T, Bromberg J, Murphy B, de Boccardo G.
    Transplantation; 2010 Jan 27; 89(2):215-21. PubMed ID: 20098285
    [Abstract] [Full Text] [Related]

  • 11. Management of chronic allograft dysfunction by switch over to rapamycin.
    Sundaram V, Abraham G, Fathima N, Sundaram V, Reddy YN, Mathew M, Sathiah V.
    Saudi J Kidney Dis Transpl; 2010 Jan 27; 21(1):37-42. PubMed ID: 20061690
    [Abstract] [Full Text] [Related]

  • 12. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients.
    Doucette KE, Pang XL, Jackson K, Burton I, Carbonneau M, Cockfield S, Preiksaitis JK.
    Transplantation; 2008 Jun 27; 85(12):1733-6. PubMed ID: 18580464
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes of calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.
    Mackay AJ, Angus PW, Gow PJ.
    Transplant Proc; 2011 Dec 27; 43(10):3802-6. PubMed ID: 22172850
    [Abstract] [Full Text] [Related]

  • 14. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 27; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 15. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C.
    Transplant Proc; 2011 Feb 27; 43(6):2187-90. PubMed ID: 21839229
    [Abstract] [Full Text] [Related]

  • 16. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 27; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 17. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
    Vallejos A, Alperovich G, Moreso F, Cañas C, de Lama ME, Gomà M, Fulladosa X, Carrera M, Hueso M, Grinyó JM, Serón D.
    Nephrol Dial Transplant; 2005 Nov 27; 20(11):2511-6. PubMed ID: 16077142
    [Abstract] [Full Text] [Related]

  • 18. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
    Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C.
    Pediatr Transplant; 2006 Jun 27; 10(4):474-8. PubMed ID: 16712606
    [Abstract] [Full Text] [Related]

  • 19. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
    Liver Transpl; 2009 Dec 27; 15(12):1792-7. PubMed ID: 19938140
    [Abstract] [Full Text] [Related]

  • 20. Predictors of decline in renal function after lung transplantation.
    Barraclough K, Menahem SA, Bailey M, Thomson NM.
    J Heart Lung Transplant; 2006 Dec 27; 25(12):1431-5. PubMed ID: 17178337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.